{"component": "definition", "props": {"groups": [{"size": 103, "snippet_links": [{"key": "point-of-connection", "type": "clause", "offset": [10, 29]}], "samples": [{"hash": "6qYZJcOHv6p", "uri": "/contracts/6qYZJcOHv6p#gxp", "label": "Distributor Agreement", "score": 36.3596534729, "published": true}, {"hash": "fh4cmSIwObG", "uri": "/contracts/fh4cmSIwObG#gxp", "label": "Distributor Agreement", "score": 36.3078536987, "published": true}, {"hash": "eTKVWG8M2XQ", "uri": "/contracts/eTKVWG8M2XQ#gxp", "label": "Distributor Agreement", "score": 36.3024330139, "published": true}], "snippet": "means any Point of Connection on the Grid:", "hash": "ccd61dc96592a06a3a12245127a77465", "id": 1}, {"size": 50, "snippet_links": [{"key": "grid-exit-point", "type": "definition", "offset": [8, 23]}, {"key": "point-of-connection", "type": "clause", "offset": [34, 53]}], "samples": [{"hash": "9bnq7p4Hjqa", "uri": "/contracts/9bnq7p4Hjqa#gxp", "label": "Distributor Agreement", "score": 36.1379585266, "published": true}, {"hash": "jjeFH1jvxWL", "uri": "/contracts/jjeFH1jvxWL#gxp", "label": "Distribution Agreement", "score": 33.2332954407, "published": true}, {"hash": "13HFSxyDjie", "uri": "/contracts/13HFSxyDjie#gxp", "label": "Distributor Agreement", "score": 32.8555374146, "published": true}], "snippet": "means a Grid Exit Point that is a point of connection on the Grid:", "hash": "e2f90995159323f6dcbe820c73b2e9cc", "id": 2}, {"size": 13, "snippet_links": [], "samples": [{"hash": "k8LlMYswAdE", "uri": "/contracts/k8LlMYswAdE#gxp", "label": "License and Collaboration Agreement (BioNTech SE)", "score": 34.2320327759, "published": true}, {"hash": "9E7OkCAAW7J", "uri": "/contracts/9E7OkCAAW7J#gxp", "label": "License and Collaboration Agreement (BioNTech SE)", "score": 30.6865158081, "published": true}, {"hash": "kqSPMOMsUTv", "uri": "/contracts/kqSPMOMsUTv#gxp", "label": "License and Collaboration Agreement (BioNTech SE)", "score": 30.5906906128, "published": true}], "snippet": "means GCP, GLP or GMP or any combination thereof, as applicable.", "hash": "472be7beca2f797d601fe0fd61a2ee50", "id": 3}, {"size": 12, "snippet_links": [{"key": "compliance-with", "type": "definition", "offset": [6, 21]}, {"key": "regulatory-agency-requirements", "type": "clause", "offset": [35, 65]}, {"key": "good-clinical-practices", "type": "definition", "offset": [82, 105]}, {"key": "good-laboratory-practices", "type": "clause", "offset": [107, 132]}, {"key": "good-manufacturing-practices", "type": "clause", "offset": [134, 162]}, {"key": "good-research-practices", "type": "definition", "offset": [167, 190]}], "samples": [{"hash": "6mbmHp09FMZ", "uri": "/contracts/6mbmHp09FMZ#gxp", "label": "Research and Development Collaboration Agreement (NextCure, Inc.)", "score": 30.2758388519, "published": true}, {"hash": "avpmikwIzWh", "uri": "/contracts/avpmikwIzWh#gxp", "label": "Research and Development Collaboration Agreement (NextCure, Inc.)", "score": 30.0787124634, "published": true}, {"hash": "47nra7R4rKw", "uri": "/contracts/47nra7R4rKw#gxp", "label": "License Agreement (Nektar Therapeutics)", "score": 28.8521556854, "published": true}], "snippet": "means compliance with all relevant Regulatory Agency requirements or guidance for Good Clinical Practices, Good Laboratory Practices, Good Manufacturing Practices and Good Research Practices.", "hash": "96a6c16d51b6c09173d2edca26e15f9f", "id": 4}, {"size": 10, "snippet_links": [{"key": "good-practice", "type": "clause", "offset": [34, 47]}, {"key": "guidelines-and-regulations", "type": "clause", "offset": [56, 82]}, {"key": "good-manufacturing-practice", "type": "definition", "offset": [142, 169]}, {"key": "good-clinical-practice", "type": "clause", "offset": [177, 199]}, {"key": "good-laboratory-practice", "type": "definition", "offset": [207, 231]}, {"key": "good-distribution-practice", "type": "definition", "offset": [239, 265]}], "samples": [{"hash": "5JA6ar15H4M", "uri": "/contracts/5JA6ar15H4M#gxp", "label": "Collaboration Agreement (BioNTech SE)", "score": 32.2416152954, "published": true}, {"hash": "8n1hqPgGdOs", "uri": "/contracts/8n1hqPgGdOs#gxp", "label": "Collaboration Agreement", "score": 32.0863380432, "published": true}, {"hash": "8iL1py4wbnz", "uri": "/contracts/8iL1py4wbnz#gxp", "label": "Collaboration Agreement (BioNTech SE)", "score": 31.5516777039, "published": true}], "snippet": "means, collectively, all relevant good practice quality guidelines and regulations, encompassing such internationally recognized standards as Good Manufacturing Practice (GMP), Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Good Distribution Practice (GDP), and Good Review Practice (GRP).", "hash": "6d069c41d34d0ccc3eb9f38565227203", "id": 5}, {"size": 7, "snippet_links": [{"key": "good-practice", "type": "clause", "offset": [10, 23]}, {"key": "good-manufacturing-practices", "type": "clause", "offset": [78, 106]}, {"key": "good-laboratory-practices", "type": "clause", "offset": [108, 133]}, {"key": "good-clinical-practices", "type": "definition", "offset": [135, 158]}, {"key": "good-distribution-practices", "type": "definition", "offset": [163, 190]}], "samples": [{"hash": "j02KvuFtwed", "uri": "/contracts/j02KvuFtwed#gxp", "label": "Covid Cla Third Amendment and Restatement Agreement (CureVac N.V.)", "score": 33.3203277588, "published": true}, {"hash": "fyRsltWnB86", "uri": "/contracts/fyRsltWnB86#gxp", "label": "2020 Cla Amendment and Restatement Agreement (CureVac N.V.)", "score": 32.3182754517, "published": true}, {"hash": "6P8uO394Fqf", "uri": "/contracts/6P8uO394Fqf#gxp", "label": "Covid Collaboration and License Agreement (CureVac N.V.)", "score": 32.3182754517, "published": true}], "snippet": "means the good practice regulations in the pharmaceutical industry, including Good Manufacturing Practices, Good Laboratory Practices, Good Clinical Practices and Good Distribution Practices (GMP, GLP, GCP and GDP).", "hash": "629a34e45e262b0687a2dc239af3ed96", "id": 6}, {"size": 6, "snippet_links": [{"key": "other-applicable", "type": "clause", "offset": [42, 58]}, {"key": "generally-accepted", "type": "clause", "offset": [60, 78]}, {"key": "best-practice-standards", "type": "definition", "offset": [88, 111]}], "samples": [{"hash": "7QNwBbdZbJh", "uri": "/contracts/7QNwBbdZbJh#gxp", "label": "Merger Agreement (Urovant Sciences Ltd.)", "score": 31.8665294647, "published": true}, {"hash": "2pOAu50yKC0", "uri": "/contracts/2pOAu50yKC0#gxp", "label": "Merger Agreement (Sumitomo Chemical Co., Ltd.)", "score": 31.8637924194, "published": true}, {"hash": "dLcojCHrTtT", "uri": "https://ir.urovant.com/static-files/1eac2ade-6454-4e00-8067-9d912f63c2b0", "label": "ir.urovant.com", "score": 10.4332647324, "published": false}], "snippet": "means, collectively, cGCP, cGLP, cGMP and other applicable, generally accepted industry best practice standards for the pharmaceutical or biotech industry.", "hash": "2da7ccd8ed159b8cc33fa0ec88755f2b", "id": 7}, {"size": 6, "snippet_links": [{"key": "point-of-connection", "type": "clause", "offset": [10, 29]}], "samples": [{"hash": "9qWecZhh7VD", "uri": "/contracts/9qWecZhh7VD#gxp", "label": "Default Agreement \u2013 Provision and Use of Consumption Data", "score": 35.7561340332, "published": true}, {"hash": "bwpoPcFGtJw", "uri": "/contracts/bwpoPcFGtJw#gxp", "label": "Default Agreement \u2013 Provision of Consumption Data", "score": 26.5742645264, "published": true}, {"hash": "3dJxL48aJla", "uri": "/contracts/3dJxL48aJla#gxp", "label": "Default Agreement \u2013 Distributions on Behalf of Distributor", "score": 23.7453804016, "published": true}], "snippet": "means any Point of Connection on the Grid: at which electricity predominantly flows out of the Grid; or", "hash": "4f1911f7673dce710a5df3595c73383c", "id": 8}, {"size": 5, "snippet_links": [{"key": "good-clinical-practices", "type": "definition", "offset": [21, 44]}, {"key": "good-laboratory-practices", "type": "clause", "offset": [46, 71]}, {"key": "good-manufacturing-practices", "type": "clause", "offset": [73, 101]}, {"key": "other-applicable", "type": "clause", "offset": [106, 122]}, {"key": "generally-accepted", "type": "clause", "offset": [124, 142]}, {"key": "best-practice-standards", "type": "definition", "offset": [152, 175]}], "samples": [{"hash": "l7KBMMG6GrL", "uri": "/contracts/l7KBMMG6GrL#gxp", "label": "Agreement and Plan of Merger (Biomarin Pharmaceutical Inc)", "score": 36.9644079398, "published": true}, {"hash": "95jrRCF2kna", "uri": "/contracts/95jrRCF2kna#gxp", "label": "Merger Agreement (Amicus Therapeutics, Inc.)", "score": 36.9644079398, "published": true}, {"hash": "8nTC5Mu7KQ1", "uri": "/contracts/8nTC5Mu7KQ1#gxp", "label": "Acquisition Agreement", "score": 35.5609130859, "published": true}], "snippet": "means, collectively, Good Clinical Practices, Good Laboratory Practices, Good Manufacturing Practices and other applicable, generally accepted industry best practice standards for the pharmaceutical or biotech industry.", "hash": "4e3623221f1e100db2f21e242468f756", "id": 9}, {"size": 4, "snippet_links": [{"key": "good-distribution-practice", "type": "definition", "offset": [6, 32]}, {"key": "according-to", "type": "definition", "offset": [58, 70]}], "samples": [{"hash": "jAKkSLWska7", "uri": "/contracts/jAKkSLWska7#gxp", "label": "Commercial Manufacturing and Supply Agreement (Oasmia Pharmaceutical AB)", "score": 26.6153316498, "published": true}, {"hash": "Z4AWqLK1rQ", "uri": "/contracts/Z4AWqLK1rQ#gxp", "label": "Master Manufacturing and Supply Agreement (Oasmia Pharmaceutical AB)", "score": 26.6153316498, "published": true}, {"hash": "8q7YYtEO3LP", "uri": "/contracts/8q7YYtEO3LP#gxp", "label": "Master Manufacturing and Supply Agreement (Oasmia Pharmaceutical AB)", "score": 26.4428482056, "published": true}], "snippet": "means Good Distribution Practice or Good Storage Practice according to FDA and EMA.", "hash": "ca1ed9a927b7fe570b73771a6d7581e2", "id": 10}], "next_curs": "ClASSmoVc35sYXdpbnNpZGVyY29udHJhY3RzciwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIMZ3hwIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"size": 250, "title": "GXP", "snippet": "means any Point of Connection on the Grid:", "id": "gxp", "examples": ["The Distributor will provide the Retailer at least 20 Working Days\u2019 notice of the date on which the commissioning of or permanent disconnection from the <strong>GXP</strong> is expected to be complete, and this agreement will be deemed to be varied from that date to the extent necessary as a result of the commissioning or permanent disconnection.", "The Distributor will provide the Retailer at least 20 Working Days&#x27; notice of the date on which the commissioning of or permanent disconnection from the <strong>GXP</strong> is expected to be complete, and this agreement will be deemed to be varied from that date to the extent necessary as a result of the commissioning or permanent disconnection.", "Baxter shall be permitted to store Product and Components in third party storage facilities qualified by Baxter, compliant to <strong>GXP</strong>.", "With respect to dedicated equipment and 3rd party work orders (such as lipid orders, mRNA, and <strong>GXP</strong> formulation batches), Providence will be solely responsible to purchase those items directly.", "Licensee shall be responsible for all costs and expenses reasonably incurred by Duality in relation to or as a result of such replacement; provided that if the replacement was caused by a breach of the applicable terms of this Agreement, Applicable Laws or the <strong>GXP</strong> by Duality, the costs and expenses reasonably incurred by Licensee in relation or as a result of such replacement shall be borne by Duality.", "Unless the variation is to pass on cost changes to the Distributor provided for under any contract or agreement relating to the use of Transpower\u2019s network, the Distributor may not exercise its rights pursuant to this Clause and vary the Charges or the pricing methodology, (such as <strong>GXP</strong> based pricing) more than once in any period of 12 months.", "Od\u0161kodn\u011bn\u00e9 strany musely dodr\u017eovat v\u0161echny p\u0159\u00edslu\u0161n\u00e9 n\u00e1rodn\u00ed, mezin\u00e1rodn\u00ed a/nebo nadn\u00e1rodn\u00ed z\u00e1kony, na\u0159\u00edzen\u00ed a sm\u011brnice <strong>GXP</strong>, a 6.", "Hospira requires all contract laboratories to operate in compliance with <strong>GXP</strong>, compendia requirements and any other applicable regulations.", "The Distributor will provide the Trader at least 20 Working Days&#x27; notice of the date on which the commissioning of or permanent disconnection from the <strong>GXP</strong> is expected to be complete, and this agreement will be deemed to be varied from that date to the extent necessary as a result of the commissioning or permanent disconnection.", "Time sync GPS or NTP GPS or NTP Data Manipulation \u2587\u2587\u2587 will carry out any data manipulation and processing required to align Summary information by <strong>GXP</strong> and Detailed information by AUFLS system to a common time scale before it is submitted to SO."], "related": [["cmc", "CMC", "CMC"], ["tdsat", "TDSAT", "TDSAT"], ["sti", "STI", "STI"], ["pmo", "PMO", "PMO"], ["gcp", "GCP", "GCP"]], "related_snippets": [], "updated": "2025-12-23T05:49:05+00:00"}, "json": true, "cursor": ""}}